CN1039119C - 稠合杂环酮衍生物,它们的制备和应用 - Google Patents

稠合杂环酮衍生物,它们的制备和应用 Download PDF

Info

Publication number
CN1039119C
CN1039119C CN93102438A CN93102438A CN1039119C CN 1039119 C CN1039119 C CN 1039119C CN 93102438 A CN93102438 A CN 93102438A CN 93102438 A CN93102438 A CN 93102438A CN 1039119 C CN1039119 C CN 1039119C
Authority
CN
China
Prior art keywords
alkyl
compound
group
phenyl
carbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN93102438A
Other languages
English (en)
Chinese (zh)
Other versions
CN1078969A (zh
Inventor
后藤义一
宫本政臣
石原雄二
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of CN1078969A publication Critical patent/CN1078969A/zh
Application granted granted Critical
Publication of CN1039119C publication Critical patent/CN1039119C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
CN93102438A 1992-03-09 1993-03-09 稠合杂环酮衍生物,它们的制备和应用 Expired - Fee Related CN1039119C (zh)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP5096092 1992-03-09
JP097948/92 1992-04-17
JP9794892 1992-04-17
JP145852/92 1992-06-05
JP14585292 1992-06-05
JP210225/92 1992-08-06
JP21022592 1992-08-06
JP259606/92 1992-09-29
JP25960692 1992-09-29
JP050960/92 1993-03-09

Publications (2)

Publication Number Publication Date
CN1078969A CN1078969A (zh) 1993-12-01
CN1039119C true CN1039119C (zh) 1998-07-15

Family

ID=27522916

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93102438A Expired - Fee Related CN1039119C (zh) 1992-03-09 1993-03-09 稠合杂环酮衍生物,它们的制备和应用

Country Status (11)

Country Link
EP (1) EP0560235B1 (US07229986-20070612-C00147.png)
CN (1) CN1039119C (US07229986-20070612-C00147.png)
AT (1) ATE154020T1 (US07229986-20070612-C00147.png)
CA (1) CA2091216A1 (US07229986-20070612-C00147.png)
DE (1) DE69311165T2 (US07229986-20070612-C00147.png)
FI (1) FI931011A (US07229986-20070612-C00147.png)
HU (1) HUT67283A (US07229986-20070612-C00147.png)
MX (1) MX9301240A (US07229986-20070612-C00147.png)
NO (1) NO930783L (US07229986-20070612-C00147.png)
NZ (1) NZ245974A (US07229986-20070612-C00147.png)
TW (1) TW218875B (US07229986-20070612-C00147.png)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639748A (en) * 1991-08-05 1997-06-17 Smithkline Beecham Corporation 6,9-disubstituted benzazepines having α-adrenoceptor blocking activity
US5620973A (en) * 1993-11-30 1997-04-15 Takeda Chemical Industries, Ltd. Tetracyclic condensed heterocyclic compounds and their use
US5705501A (en) * 1994-11-17 1998-01-06 Molecular Geriatrics Corporation Certain substituted 1-aryl-3-morpholinopropanones to treat Alzheimer's Disease
US5658909A (en) 1994-11-17 1997-08-19 Molecular Geriatrics Corporation Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's Disease
GB2308362A (en) * 1995-12-19 1997-06-25 Lilly Industries Ltd Pharmaceutical indole derivatives
AU6852898A (en) * 1997-04-17 1998-11-11 Takeda Chemical Industries Ltd. Thermogenic composition and benzazepine thermogenics
WO1999053909A2 (en) * 1998-04-23 1999-10-28 Takeda Chemical Industries, Ltd. Pharmaceutical composition for neurotrophic action
AU758802B2 (en) 1998-09-30 2003-03-27 Takeda Pharmaceutical Company Limited Drugs for improving vesical excretory strength
US7229986B2 (en) 2000-05-16 2007-06-12 Takeda Pharmaceutical Company Ltd. Melanin-concentrating hormone antagonist
CA2414976A1 (en) * 2000-07-04 2002-01-10 Takeda Chemical Industries, Ltd. Gpr14 antagonistic agent
US20040053826A1 (en) * 2000-08-10 2004-03-18 Yoshio Matsumoto Uses of polypeptides
AU2002367425B2 (en) 2001-12-28 2006-03-09 Takeda Pharmaceutical Company Limited Preventives/remedies for urinary disturbance
GB201106817D0 (en) 2011-04-21 2011-06-01 Astex Therapeutics Ltd New compound
GB201218850D0 (en) 2012-10-19 2012-12-05 Astex Therapeutics Ltd Bicyclic heterocycle compounds and their uses in therapy
GB201218862D0 (en) 2012-10-19 2012-12-05 Astex Therapeutics Ltd Bicyclic heterocycle compounds and their uses in therapy
US9980973B2 (en) 2012-10-19 2018-05-29 Astex Therapeutics Limited Bicyclic heterocycle compounds and their uses in therapy
GB201218864D0 (en) 2012-10-19 2012-12-05 Astex Therapeutics Ltd Bicyclic heterocycle compounds and their uses in therapy
SG11201604795RA (en) 2013-12-20 2016-07-28 Astex Therapeutics Ltd Bicyclic heterocycle compounds and their uses in therapy
CN115433116B (zh) * 2022-09-20 2023-07-14 徐州医科大学 一种酰化吲哚啉类衍生物、组合物及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035228A1 (en) * 1980-02-29 1981-09-09 Otsuka Pharmaceutical Co., Ltd. Tetrazole derivatives, process for the preparation thereof, and anti-ulcer composition containing the same
EP0229391A1 (en) * 1985-12-27 1987-07-22 Eisai Co., Ltd. Piperidine derivate, its use and pharmaceutical composition containing it
US4916128A (en) * 1987-06-06 1990-04-10 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521606A (en) * 1983-06-30 1985-06-04 American Home Products Corp. 5-Indolyl substituted aminoethanols
JP2699511B2 (ja) * 1988-01-29 1998-01-19 武田薬品工業株式会社 置換アミン類
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
TW197435B (US07229986-20070612-C00147.png) * 1990-11-22 1993-01-01 Takeda Pharm Industry Co Ltd

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035228A1 (en) * 1980-02-29 1981-09-09 Otsuka Pharmaceutical Co., Ltd. Tetrazole derivatives, process for the preparation thereof, and anti-ulcer composition containing the same
EP0229391A1 (en) * 1985-12-27 1987-07-22 Eisai Co., Ltd. Piperidine derivate, its use and pharmaceutical composition containing it
US4916128A (en) * 1987-06-06 1990-04-10 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones

Also Published As

Publication number Publication date
EP0560235B1 (en) 1997-06-04
AU3380393A (en) 1993-09-16
DE69311165D1 (de) 1997-07-10
AU658481B2 (en) 1995-04-13
HU9300659D0 (en) 1993-05-28
EP0560235A1 (en) 1993-09-15
DE69311165T2 (de) 1997-09-18
CA2091216A1 (en) 1993-09-10
TW218875B (US07229986-20070612-C00147.png) 1994-01-11
FI931011A0 (fi) 1993-03-08
NZ245974A (en) 1995-04-27
ATE154020T1 (de) 1997-06-15
CN1078969A (zh) 1993-12-01
NO930783L (no) 1993-09-10
MX9301240A (es) 1993-12-01
NO930783D0 (no) 1993-03-03
HUT67283A (en) 1995-03-28
FI931011A (fi) 1993-09-10

Similar Documents

Publication Publication Date Title
CN1039119C (zh) 稠合杂环酮衍生物,它们的制备和应用
JP2650537B2 (ja) 縮合複素環誘導体
CN1028104C (zh) 制备喹诺酮衍生物的方法
US5308854A (en) Inhibitors of HIV reverse transcriptase
CN1309704C (zh) 邻氨基苯甲酸酰胺及其作为药物的应用
AU2001260310B2 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
US6175015B1 (en) Fused indolecarboxamides: dopamine receptor subtype specific ligands
CN1118598A (zh) 吡咯并吡啶衍生物
CN1708481A (zh) 作为抗微生物剂的n-烷基-4-亚甲基氨基-3-羟基-2-吡啶酮
CN1662497A (zh) N-[苯基(哌啶-2-基)甲基]苯甲酰胺衍生物,其制备方法及其在治疗中的应用
CN1143953A (zh) 某些稠合n-吡咯甲酰苯胺;一类新的脑gaba受体配体
CN1127498C (zh) 吡啶衍生物、制备吡啶衍生物的方法及其中间体
JPS6289679A (ja) ピペリジン誘導体
CN1234797A (zh) N-取代的氮杂环化合物
AU2001260310A1 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
WO1998006717A9 (en) Fused indolecarboxamides: dopamine receptor subtype specific ligands
AU2013286523B2 (en) Benzodioxole derivative and preparation method and use thereof
US20050148583A1 (en) Phenoxyalkylamine derivatives useful as opioid delta receptor ligands
CN1071754C (zh) 嘧啶基吡唑衍生物
CN1780838A (zh) 新型二氮杂双环壬烯衍生物
CN1064275A (zh) 咪唑并吡啶paf/h1拮抗剂
CN1069491A (zh) 2-(哌啶-1-基)乙醇衍生物,其制法及其治疗应用
EP0809642A1 (en) Imidazo 1,2-a]pyridines for the treatment of cns and cardiac diseases
US6242448B1 (en) Trisubstituted-oxazole derivatives as serotonin ligands
CN1266134C (zh) 稠合多环化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee